Online inquiry

IVTScrip™ mRNA-Human ANKRD10, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK16697MR)

This product GTTS-WK16697MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ANKRD10 protein. This product can be used in Exhausted CD8+ T cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001286721.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 55608
UniProt ID Q9NXR5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD10, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK16697MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25059MR IVTScrip™ mRNA-Human ARMCX2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARMCX2
GTTS-WK28339MR IVTScrip™ mRNA-Human ARL2BP, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARL2BP
GTTS-WK20331MR IVTScrip™ mRNA-Human ANKRD54, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD54
GTTS-WK8931MR IVTScrip™ mRNA-Human ADGB, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGB
GTTS-WK16131MR IVTScrip™ mRNA-Human ANKRD54, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD54
GTTS-WK22006MR IVTScrip™ mRNA-Human ARHGEF1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF1
GTTS-WK7276MR IVTScrip™ mRNA-Human ABI3BP, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ABI3BP
GTTS-WK23268MR IVTScrip™ mRNA-Human ARPC3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARPC3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →